Skip to main content

MoneyWorks4Me

Bacil Pharma informs about certificate

18 Oct 2022 Evaluate

Bacil Pharma has informed that it attached certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter and half year ended September 30, 2022 received from Registrar and Transfer Agent of the Company - ‘Big share Services’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1885.10
Dr. Reddys Labs. 1380.75
Cipla 1410.15
Lupin 2018.50
Zydus Lifesciences 1202.00
View more..